Chemomab Therapeutics Ltd.

CMMB - Company ID 0001534248

Market cap-

Rank-

Filings345

Chemomab Therapeutics Ltd. has filed 345 public company documents between 2011 and 2026. The most frequent type is 6-k (60 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchCMMB overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut CMMB beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow CMMB via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	1mo ago2026-05-14	2026-05-14	View filing
6-K	6-K	2mo ago2026-05-06	2026-05-06	View filing
6-K	6-K	2mo ago2026-04-28	2026-04-28	View filing
3	New insider ownership	3mo ago2026-04-10	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-10	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-10	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-10	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-10	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-10	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-31	2026-03-18	View filing
3	New insider ownership	3mo ago2026-03-31	2026-03-18	View filing
20-F	20-F	3mo ago2026-03-23	2025-12-31	View filing
6-K	6-K	3mo ago2026-03-20	2026-03-20	View filing
6-K	6-K	3mo ago2026-03-19	2026-03-19	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	4mo ago2026-02-17	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	5mo ago2026-02-10	-	View filing
6-K	6-K	7mo ago2025-11-21	2025-11-21	View filing
6-K	6-K	10mo ago2025-08-22	2025-08-22	View filing
6-K	6-K	11mo ago2025-08-14	2025-06-30	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	11mo ago2025-08-11	-	View filing
6-K	6-K	11mo ago2025-07-25	2025-07-25	View filing
424B5	Prospectus supplement	11mo ago2025-07-25	-	View filing
6-K	6-K	1y ago2025-07-01	2025-07-01	View filing
SCHEDULE 13D/A	SCHEDULE 13D/A	1y ago2025-06-23	-	View filing
6-K	6-K	1y ago2025-05-27	2025-05-27	View filing
6-K	6-K	1y ago2025-05-15	2025-05-15	View filing
6-K	6-K	1y ago2025-04-15	2025-04-15	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-04-10	-	View filing
20-F	20-F	1y ago2025-04-04	2024-12-31	View filing
6-K	6-K	1y ago2025-03-27	2025-03-27	View filing
6-K	6-K	1y ago2025-03-20	2025-03-20	View filing
6-K	6-K	1y ago2025-03-03	2025-03-03	View filing
6-K	6-K	1y ago2025-02-19	2025-02-19	View filing
EFFECT	EFFECT	1y ago2024-12-10	-	View filing
POS AM	POS AM	1y ago2024-12-02	-	View filing
SC 13D/A	Activist ownership stake (update)	1y ago2024-11-29	-	View filing
SC 13G	Passive ownership stake	1y ago2024-11-21	-	View filing
6-K	6-K	1y ago2024-11-18	2024-11-18	View filing
424B5	Prospectus supplement	1y ago2024-11-15	-	View filing
6-K	6-K	1y ago2024-11-14	2024-11-14	View filing
6-K	6-K	1y ago2024-10-11	2024-10-11	View filing
SC 13D/A	Activist ownership stake (update)	1y ago2024-09-16	-	View filing
144	Insider sale notice	1y ago2024-09-12	-	View filing
424B3	424B3	1y ago2024-09-09	-	View filing
EFFECT	EFFECT	1y ago2024-09-06	-	View filing
CORRESP	Company correspondence	1y ago2024-09-04	-	View filing
UPLOAD	SEC correspondence	1y ago2024-08-29	-	View filing
F-3	F-3	1y ago2024-08-23	-	View filing
6-K	6-K	1y ago2024-08-21	2024-06-30	View filing
SC 13G	Passive ownership stake	1y ago2024-08-20	-	View filing

Chemomab Therapeutics Ltd.

Similar companies to research next

Year